KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Nektar Therapeutics (NKTR) over the last 16 years, with Dec 2024 value amounting to $4.2 million.

  • Nektar Therapeutics' Other Working Capital Changes fell 82.73% to $618,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 205.06%. This contributed to the annual value of $4.2 million for FY2024, which is 216.86% up from last year.
  • According to the latest figures from FY2024, Nektar Therapeutics' Other Working Capital Changes is $4.2 million, which was up 216.86% from -$3.6 million recorded in FY2023.
  • In the past 5 years, Nektar Therapeutics' Other Working Capital Changes ranged from a high of $4.2 million in FY2024 and a low of -$6.9 million during FY2022.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$3.6 million (2023), whereas its average is -$2.1 million.
  • As far as peak fluctuations go, Nektar Therapeutics' Other Working Capital Changes tumbled by 367.05% in 2022, and later surged by 216.86% in 2024.
  • Nektar Therapeutics' Other Working Capital Changes (Yearly) stood at -$5.5 million in 2020, then surged by 146.88% to $2.6 million in 2021, then slumped by 367.05% to -$6.9 million in 2022, then surged by 48.12% to -$3.6 million in 2023, then skyrocketed by 216.86% to $4.2 million in 2024.